ClinicalTrials.Veeva

Menu

Oxygen Extraction and Delivery in Elderly During Major Surgery

Karolinska Institute logo

Karolinska Institute

Status

Completed

Conditions

Postoperative Complications
Impaired Oxygen Delivery
Peroperative Complication
Surgery

Treatments

Other: General anaesthesia and major surgery

Study type

Observational

Funder types

Other

Identifiers

NCT03355118
4-500/2017 (Other Identifier)
K2017-0373

Details and patient eligibility

About

This clinical observational study investigates perioperative oxygen consumption and delivery in elderly patients undergoing major surgery. The primary objectives are to characterise the perioperative oxygen delivery, consumption and potential markers of oxygen debt. Secondary objective is to estimate the correlation between oxygen delivery/consumption and postoperative outcomes to guide the design of a future trial.

Full description

Background Intra- and postoperative fluid therapy aims to achieve or maintain pre-specified thresholds of oxygen delivery/blood flow which can be accomplished by use of fluids with or without inotropic drugs. The used thresholds of oxygen delivery were suggested over 40 years ago, in considerably younger patients compared to the current patients. Update of the characteristics of perioperative oxygen delivery and consumption is reasonable in modern clinical settings.

Primary outcome:

relative changes of oxygen consumption induced by anaesthesia

Secondary outcomes:

relative changes of oxygen consumption and delivery during surgery and postoperatively, oxygen extraction ratio (measured and estimated), potential markers of oxygen debt frequency of in-hospital postoperative complications, mortality (30 Days)

Population:

Men and women ≥65 years undergoing major/complex surgical procedures, when intra-operative cardiovascular monitoring is justified according to clinical decision.

Intervention: no study related intervention, general anaesthesia and surgery according to clinical routine

Blinding: no blinding

Study size:

Pilot study 1: feasibility assessment of study protocol of intra-operative measurements (n= max 10) Pilot study 2: feasibility assessment of study protocol of postoperative measurements (n= max 10) Main study: 60 subjects (20+´40) Planned analysis of oxygen consumption after 20 monitored subjects

Study duration:

Duration of haemodynamic monitoring 24-36 hours Duration of observation of clinical outcomes: 7-10 days, mortality at 30 days postop.

Investigational events:

monitoring of oxygen consumption and delivery monitoring of postoperative clinical outcomes monitoring of markers of tissue injury

Assessments, Procedures and Schedule of Investigational Events:

Subjects are identified by the operation planning list and assessed for eligibility. The study information will be given verbal during the first hospital visit. Subjects who give written informed consent will be included in the study.

Measurements:

oxygen consumption by indirect calorimetry via face mask (in awake state) and via expiratory extension tube of anaesthesia machine (unconscious state) cardiac output monitoring via arterial line (LiDCO) blood samples: arterial and venous blood gase samples, Troponin-T urine samples: N-gal

Clinical outcomes:

Data collection from medical records on postoperative complications using the POMS (postoperative morbidity survey) screening survey at days 3,7 and 10. Postoperative mortality at day 30.

Enrollment

20 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Men and women aged ≥65 years
  2. Major/complex surgery (BUPA AXA classification of surgical severity)
  3. Central and arterial venous catheterization for hemodynamic monitoring.
  4. Written informed consent
  5. Available research team for the measurements If two subjects are eligible the elder one will be chosen. If there are two subjects eligible of different gender and almost the same age, the subject with a gender that is underrepresented by two or more will be chosen. This is consistent with the purpose of including subjects with as high age as possible without interfering with recruitment.

Exclusion Criteria

  1. Concomitant medication with Lithium (interferes with calibration of the LiDCO monitor)
  2. Weight≤ 40 kg.
  3. Not possible to establish arterial or central venous line.
  4. Planned postoperative care at high-dependency unit (POP/IMA) <12hrs.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems